D. Werner

发表

Is Protein Kinase Substrate Efficacy a Reliable Barometer for Successful Inhibitor Design? (*)

D. Lawrence, D. Werner, T. R. Lee, 1996, The Journal of Biological Chemistry.

Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IR.

D. Werner, P. Gokhale, E. May, 2010, ACS medicinal chemistry letters.

A Novel, Nonpeptidic, Orally Active Bivalent Inhibitor of Human β-Tryptase

F. Barany, D. Werner, S. Giardina, 2018, Pharmacology.

Target-Directed Self-Assembly of Homodimeric Drugs Against β-Tryptase

F. Barany, D. Werner, S. Giardina, 2018, ACS medicinal chemistry letters.

Synthetic approaches to 5,7-disubstituted imidazo[5,1-f][1,2,4]triazin-4-amines

D. Werner, Hanqing Dong, A. Crew, 2010 .

A highly effective one-pot synthesis of quinolines from o-nitroarylcarbaldehydes.

M. Cox, Qinghua Weng, D. Werner, 2007, Organic & biomolecular chemistry.

One-Pot FriedländerQuinoline Synthesis: Scope and Limitations

D. Werner, A. Crew, Kam W. Siu, 2010 .

1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors.

M. Cox, Qinghua Weng, D. Werner, 2007, Bioorganic & medicinal chemistry letters.

Reversible Linkage of Two Distinct Small Molecule Inhibitors of Myc Generates a Dimeric Inhibitor with Improved Potency That Is Active in Myc Over-Expressing Cancer Cell Lines

F. Barany, Jutta Wanner, D. Werner, 2015, PloS one.

Imidazo[1,5-a]pyrazines: orally efficacious inhibitors of mTORC1 and mTORC2.

D. Werner, P. Gokhale, N. Gibson, 2011, Bioorganic & medicinal chemistry letters.

Novel, Self-Assembling Dimeric Inhibitors of Human β Tryptase.

F. Barany, D. Werner, S. Giardina, 2020, Journal of medicinal chemistry.